Publikationen von weiteren Studien

PAPI study

  1. Wetzke M, Le DB, Tometten I, Ritter S, Lübke N, Timm J, Dilthey A, Panning M, Walker A, Happle C. (2025) Prevalence of Resistance-Associated Mutations in RSV F Protein Against Monoclonal Antibodies Prior to Widespread Implementation: Findings From a Prospective German Pediatric Cohort. Influenza Other Respir Viruses. 19(9):e70164. doi: 10.1111/irv.70164

  2. Bähre J, Lange M, Salaschek P, Twardella D, Arens S, Eberhard F, Barten- Neiner G, Panning M, Köster H, Körner-Rettberg C, Wetzke M, Happle C. (2025)  Distinct seasonality and increased respiratory failure in RSV patients < 2 years of age after emergence of SARS-CoV-2: data from the multicentric, prospective PAPI study.  Eur J Pediatr. 184(4):246. doi: 10.1007/s00431-025-06057-0

  3. Wetzke M, Lange M, Koerner-Rettberg C, Kiefer A, Kabesch M, Armbrust S, Abdelkhalek K, Lex C, Hufnagel M, Bode S, Dördelmann M, Lorenz M, Arens S, Panning M, Köster H, Kramer R, Bangert M, Eberhardt F, Barten- Neiner G, Happle C. (2025) RSV is the main cause of severe respiratory infections in infants and young children in Germany – data from the prospective, multicenter PAPI study 2021-2023. Infection. doi: 10.1007/s15010-025-02484-1

Pulmonary Emphysema Registry eV

  1. Saccomanno J, Elgeti T, Spiegel S, Pappe E, Sgarbossa T, Petersen A, Neumann K, Mall MA, Witzenrath M, Hübner RH. Association of Mucus Plugging and Body Mass Index in Patients With Advanced COPD GOLD 3/4 With Emphysema. Chronic Obstr Pulm Dis. 2025 Oct 3. doi: 10.15326/jcopdf.2025.0617

  2. Saccomanno J, Kilic L, Sgarbossa T, Neumann K, Stanzel F, Holland A, Grah C, Gesierich W, Krist J, Ficker JH, Eggeling S, Andreas S, Schmidt B, Eisenmann S, Schwick B, Franke KJ, Fertl A, Witzenrath M, Hübner RH. (2025) Clinical improvements after endoscopic lung volume reduction with valves in patients with advanced emphysema and a 6-min walk test ≤140 m at baseline. ERJ Open Res. 11(1):00410-2024. doi: 10.1183/23120541.00410-2024

  3. Grah C, Oei SL, Krist J, Wiesemann B, Schmidt B, Fertl A, Schwick B, Hübner RH, Becke B, Franke KJ, Geltner C, Eisenmann S, Stanzel F, Barten- Neiner G, Sgarbossa T, Blazejczyk K, Wüstefeld H. (2025)  Efficacy and Safety of Lung Volume Reduction with Endobronchial Coil #2 and Coil #4 Results of the German Emphysema Registry-Lungenemphysemaregister eV. COPD  22(1): doi: 10.1080/15412555.2025.2468328

  4. Rummenholl M, Sgarbossa T, Grah C, Holland A, Hübner RH. (2025) Das Lungenemphysemregister e.V.: Verbesserung der Versorgungsqualität bei interventioneller Emphysemtherapie und Gesundheitsmanagement für Patient*innen mit fortgeschrittener COPD und  lungenemphysem [The Lung Emphysema Registry: Improving quality of care in interventional emphysema therapy and health
    management for patients with advanced COPD and lung emphysema]    . Pneumologie. 79(9):661-666. German. doi: 10.1055/a-2532-4885

  5. Sgarbossa T, Borchers P, Saccomanno J, Ahrens K, Wüstefeld HF, Pappe E, Wuelfing U, Klein U, Witzenrath M, Stanzel F, Grah C, Hübner RH. (2025) Comparison of Efficacy and Safety of Different Types of One-Way Valves in Endoscopic Lung Volume Reduction in Patients with Severe Lung Emphysema. Respiration. 104(4):281-289. doi: 10.1159/000542806

  6. Saccomanno J, Sgarbossa T, Pappe E, Kilic L, Biglari S, Shargill NS, Radhakrishnan S, Witzenrath M, Hübner RH. (2024) VT20 method for Chartis assessment of collateral ventilation with flexible bronchoscopy under procedural sedation. ERJ Open Res. 10(4):00945-2023. doi: 10.1183/23120541.00945-2023

  7. Pappe E, Hübner RH, Saccomanno J, Ebrahimi HDN, Witzenrath M, Wiessner A, Sarbandi K, Xiong Z, Kursawe L, Moter A, Kikhney J. (2024)  Biofilm infections of endobronchial valves in COPD patients after endoscopic lung volume reduction: a pilot study with FISHseq. Sci Rep  14(1):23078.  doi: 10.1038/s41598-024-73950-3 

  8. Sgarbossa T, Lenga P, Stanzel F, Holland A, Grah C, Gesierich W, Gebhardt A, Ficker J, Eggeling S, Andreas S, Schmidt B, Eisenmann S, Schwick B, Franke KJ, Fertl A, Witzenrath M, Hübner RH. (2023) Assessment of efficacy and safety of endoscopic lung volume reduction with one-way valves in patients with a very low FEV1. ERJ Open Res. 9(4):00190-2023. doi: 10.1183/23120541.00190-2023

  9. Pappe E, Hammerich R, Saccomanno J, Sgarbossa T, Pohrt A, Schmidt B, Grah C, Eisenmann S, Holland A, Eggeling S, Stanzel F, Witzenrath M, Hübner RH. (2023) Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD. Chronic Obstr Pulm Dis. 10(3):211-223. doi: 10.15326/jcopdf.2022.0383

  10. Saccomanno J, Ruwwe-Glösenkamp C, Neumann K, Doellinger F, Lenga P, Pappe E, Suttorp N, Witzenrath M, Hübner RH. (2022) Impact of Ventilation Modes on Bronchoscopic Chartis Assessment Outcome in Candidates for Endobronchial Valve Treatment. Respiration 101(4):408-416. doi: 10.1159/000520082